Search Results

You are looking at 71 - 80 of 90 items for :

  • Medical and Health Sciences x
  • Refine by Access: All Content x
Clear All

psychedelic substances for the treatment of psychological disorders. This has included the administration of a range of substances, including LSD, psilocybin, ayahuasca, methylenedioxymethamphetamine (MDMA), and ibogaine, in conjunction with psychotherapy for

Open access

Introduction Psychedelic drugs like lysergic acid diethylamide (LSD-25), 3,4-methylenedioxymethamphetamine (MDMA), and psilocybin are being investigated again, showing therapeutic potential for certain psychological disorders

Open access
Journal of Behavioral Addictions
Authors:
Pedro Romero
,
Andrea Czakó
,
Wim van den Brink
, and
Zsolt Demetrovics

research indicates the potential of psychedelic-assisted therapy (PAT) to treat treatment-resistant mental disorders, including various substance use disorders ( Andersen, Carhart-Harris, Nutt, & Erritzoe, 2021 ). While atypical psychedelics (e.g., MDMA

Open access
Journal of Psychedelic Studies
Authors:
Thaddeus James Camlin
,
Donald Eulert
,
Arthur Thomas Horvath
,
Steven F. Bucky
,
Joseph P. Barsuglia
, and
Martin Polanco

( Depoortere, 1987 ; Marrosu et al., 1995 ; Schneider & Sigg, 1957 ). If an ibogaine protocol is developed and psychotherapy is a part of it, as it is in the MDMA research protocol ( Mithoefer, 2017 ), then it may be worth considering the inclusion of

Open access

Introduction In the past decade, novel psychoactive substances (NPSs) gained a significant role on the contemporary drug scene. With a decreasing purity and availability of 3,4-methyl​enedioxy​methamphetamine (MDMA), cocaine

Open access

MDMA, which makes sense given that components include elemicin, eugenol, and safrole ( Nowak, Woźniakiewicz, Gładysz, Sowa, & Kościelniak, 2016 ). All of these are related to MDMA, and are found in the Holy Ointment. Furthermore, potent

Open access
Journal of Psychedelic Studies
Authors:
Kelley C. O’Donnell
,
Sarah E. Mennenga
, and
Michael P. Bogenschutz

participants with any use of psychedelics (including psilocybin, MDMA, LSD, mescaline, DMT, and other similar hallucinogenic compounds) within the last year at a minimum. Excluding use for the past 5 years may be appropriate for some study designs. However

Open access

Use of MDMA, family history of gambling, brother PG, and facial disfigurement None reported Abstinence 27 3 Evening tiredness None during treatment period

Open access

-DMT). Serotonergic hallucinogens are a subgroup of three classes of compounds: tryptamines, ergolines, and phenethylamines, of which the latter group also includes the so-called entactogens/empathogens (MDMA or 2C-B). In a broader context, the hallucinogen class

Open access
Journal of Psychedelic Studies
Authors:
Federico Cavanna
,
Carla Pallavicini
,
Virginia Milano
,
Juan Cuiule
,
Rocco Di Tella
,
Pablo González
, and
Enzo Tagliazucchi

, alcohol, tobacco, and cannabis) were linked to higher scores of dimensions linked to mental health impairment, and lower scores of dimensions linked to well-being and resilience. Within this last group of non-psychedelic drugs, MDMA showed different

Open access